Literature DB >> 27908565

Determinants of hyperhomocysteinemia in healthy and hypertensive subjects: A population-based study and systematic review.

Liyuan Han1, Yanfen Liu1, Changyi Wang2, Linlin Tang3, Xiaoqi Feng4, Thomas Astell-Burt4, Qi Wen2, Donghui Duan1, Nanjia Lu1, Guodong Xu1, Kaiyue Wang1, Lu Zhang1, Kaibo Gu1, Sihan Chen2, Jianping Ma2, Tao Zhang2, Dingyun You5, Shiwei Duan6.   

Abstract

AIMS: Hyperhomocysteinemia (HHcy) is known to increase the risk of many diseases. Factors influencing HHcy in healthy and hypertensive subjects remain under-researched.
METHODS: A large population-based study was conducted in 60 communities from Shenzhen, China. Responses to standardized questions on lifestyle factors and blood samples were collected from all participants after a 12-h overnight fast. Multiple linear and multivariate logistic regressions were used to explore risk factors for HHcy. Results were then compared to those from a systematic review of English-language articles listed in Pubmed, EBSCOhost, Web of Science, Embase and Cochrane libraries that investigated HHcy risk factors in healthy and hypertensive subjects.
RESULTS: A total of 1586 healthy (Male/Female = 642/944) and 5935 hypertensive subjects (Male/Female = 2928/3007) participated in our population-based study. In logistic regression analyses, age, BMI and creatinine (Cr) were risk factors, while being female, fruit intake and physical activity were protective factors for HHcy in healthy subjects. In hypertensive subjects, seven [age, smoking, salt intake, systolic blood pressure (SBP), uric acid, triglycerides (TG), and Cr] and four [female, fruit intake, total cholesterol (TC), and glucose] factors were associated with higher and lower HHcy respectively. The review of 71 studies revealed that potential risk factors for Hcy included nutritional, physiologic, lifestyle habits, ethnicity, genetics, interactions between gene-environment, gene-gene, gene-nutritional, environment-environment, nutritional-nutritional.
CONCLUSION: Our study indicates the potential importance of increasing folic acid and vitamin B supplementation, daily fruit and vegetable intake, regular exercise and refraining from tobacco smoking and alcohol consumption as preventive strategies for Hcy.
Copyright © 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Healthy; Homocysteine; Hyperhomocysteinemia; Hypertension

Mesh:

Substances:

Year:  2016        PMID: 27908565     DOI: 10.1016/j.clnu.2016.11.011

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  13 in total

1.  Influence of renal function on the association between homocysteine level and risk of ischemic stroke.

Authors:  Yao Cheng; Fan-Zhen Kong; Xiao-Feng Dong; Qin-Rong Xu; Qian Gui; Wei Wang; Hong-Xuan Feng; Wei-Feng Luo; Zong-En Gao; Guan-Hui Wu
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

2.  Prevalence of hyperhomocysteinemia (HHcy) and its major determinants among hypertensive patients over 35 years of age.

Authors:  Minna Cheng; Hong Xue; Xinjian Li; Qinghua Yan; Dingliang Zhu; Yan Wang; Yan Shi; Chen Fu
Journal:  Eur J Clin Nutr       Date:  2021-08-30       Impact factor: 4.016

3.  Evidence on the causal link between homocysteine and hypertension from a meta-analysis of 40 173 individuals implementing Mendelian randomization.

Authors:  Liwan Fu; Ya-Nan Li; Dongmei Luo; Shufang Deng; Baihui Wu; Yue-Qing Hu
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-25       Impact factor: 3.738

4.  Hyperhomocysteinemia and Low Folate and Vitamin B12 Are Associated with Vascular Dysfunction and Impaired Nitric Oxide Sensitivity in Morbidly Obese Patients.

Authors:  Mohamed Haloul; Smita Jagdish Vinjamuri; Dina Naquiallah; Mohammed Imaduddin Mirza; Maryam Qureshi; Chandra Hassan; Mario Masrur; Francesco M Bianco; Patrice Frederick; Giulianotti P Cristoforo; Antonio Gangemi; Mohamed M Ali; Shane A Phillips; Abeer M Mahmoud
Journal:  Nutrients       Date:  2020-07-07       Impact factor: 5.717

5.  Systemic risk factors correlated with hyperhomocysteinemia for specific MTHFR C677T genotypes and sex in the Chinese population.

Authors:  Tianyuan Xiang; Hang Xiang; Muyang Yan; Sheng Yu; Matthew John Horwedel; Yang Li; Qiang Zeng
Journal:  Ann Transl Med       Date:  2020-11

6.  Exploration of the risk factors of essential hypertension with hyperhomocysteinemia: A hospital-based study and nomogram analysis.

Authors:  Jufang Wang; Jinman Du; Rui Fan
Journal:  Clinics (Sao Paulo)       Date:  2021-01-20       Impact factor: 2.365

7.  Gender differences in risk factors for high plasma homocysteine levels based on a retrospective checkup cohort using a generalized estimating equation analysis.

Authors:  Jing Zhao; Zhihua Li; Chengbei Hou; Fei Sun; Jing Dong; Xi Chu; Yansu Guo
Journal:  Lipids Health Dis       Date:  2021-04-12       Impact factor: 3.876

8.  Association between blood marker analyses regarding physical fitness levels in Spanish older adults: A cross-sectional study from the PHYSMED project.

Authors:  Raquel Aparicio-Ugarriza; Ángel Enrique Díaz; Gonzalo Palacios; María Del Mar Bibiloni; Alicia Julibert; Josep Antoni Tur; Marcela González-Gross
Journal:  PLoS One       Date:  2018-10-24       Impact factor: 3.240

9.  Methylenetetrahydrofolate Reductase Gene C677T Polymorphism-Dietary Pattern Interaction on Hyperhomocysteinemia in a Chinese Population: A Cross-Sectional Study.

Authors:  Song Leng; Ai Zhao; Jian Zhang; Wei Wu; Qian Wang; Shan Wu; Li Chen; Qiang Zeng
Journal:  Front Cardiovasc Med       Date:  2021-06-24

10.  The effect of physical activity on total homocysteine concentrations and cardiovascular risk in older Brazilian adults with type 2 diabetes.

Authors:  José Jonas de Oliveira; Alexandre de Souza E Silva; Anna Gabriela Silva Vilela Ribeiro; Carolina Gabriela Reis Barbosa; Jasiele Aparecida de Oliveira Silva; Annie Guimarães Pontes; João Paulo Estevam Batista; Adriana Pertille
Journal:  J Diabetes Metab Disord       Date:  2021-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.